© PR Newswire
21.01.2026
AZTA
LISTED
NASDAQ
Azenta Announces Fiscal 2026 First Quarter Conference Call and Webcast
News Preview
BURLINGTON, Mass., Jan. 21, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal first quarter 2026 earnings which ended on December 31, 2025, on Wednesday, February 4, 2026, before the market opens.The Company will host a conference call and live webcast to discuss its financial results on the same day, Wednesday, February 4, 202...
Themefolio
Profiler
Peergroup
© BusinessWire
21.01.2026
DCTH
LISTED
NASDAQ
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company granted equity awards, previously approved by the Company’s Compensation Committee, as material inducements to four individuals whose employment co...
Themefolio
Profiler
Peergroup
© PR Newswire
21.01.2026
NBIX
LISTED
NASDAQ
Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2025 Financial Results
News Preview
Conference Call and Webcast Scheduled for Wednesday, February 11SAN DIEGO, Jan. 21, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that it has scheduled its fourth quarter and year-end 2025 financial results conference call and webcast for 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on February 11, 2026....
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
21.01.2026
ATXS
LISTED
NASDAQ
Astria Stockholders Vote to Approve Acquisition by BioCryst
News Preview
Astria Therapeutics, Inc. (Nasdaq: ATXS) today announced that at the special meeting of Astria’s stockholders held on January 21, 2026, Astria’s stockholders voted to approve the acquisition of Astria by BioCryst Pharmaceuticals, Inc. (the “Merger”).
The parties expect the Merger to close on or about January 23, 2026, subject to the satisfaction...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
23.01.2026
© BusinessWire
21.01.2026
ACLX
LISTED
NASDAQ
Arcellx to Advance the Conversation on Its Platform and the Importance of Early CAR T Access for Patients with Multiple Myeloma During the 2026 Tandem Meetings
News Preview
Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, is advancing both its scientific foundation for its D-Domain platform technology and commercial preparedness for anito-cel for the potential treatment of multipl...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
STE
LISTED
NYSE
STERIS to Host a Conference Call for Fiscal 2026 Third Quarter Results on February 5, 2026
News Preview
DUBLIN, IRELAND, Jan. 21, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2026 third quarter results at 9:00 a.m. ET on February 5, 2026. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the Un...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
AXGN
LISTED
NASDAQ
Axogen Announces Proposed Public Offering of Common Stock
News Preview
ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that it intends to offer and sell, subject to market and other conditions, $85.0 million of shares of its common s...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
NYXH
LISTED
NASDAQ
Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth
News Preview
Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
OPCH
LISTED
NASDAQ
Option Care Health to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call
News Preview
BANNOCKBURN, Ill., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its fourth quarter and full year 2025 on Tuesday, February 24, 2026 before the market...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
AEON
LISTED
NASDAQ
AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions
News Preview
AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
MDGL
LISTED
NASDAQ
Madrigal Pharmaceuticals Announces Grant of Inducement Award under Nasdaq Listing Rule 5635(c)(4)
News Preview
CONSHOHOCKEN, Pa., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted an equity award on January 15, 2026 to Rita Thakkar, the company’s new Chief Accounting...
Themefolio
Profiler
Peergroup
© BusinessWire
21.01.2026
LSTA
LISTED
NASDAQ
LSTA Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Lisata Therapeutics, Inc. is Fair to Shareholders
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Lisata Therapeutics, Inc. (NASDAQ: LSTA) to Kuva Labs, Inc. for $4.00 per share in cash plus two non-tradeable contingent value rights payable under certain conditions is fair to Lisata shareholders.
Halper Sadeh encourages Lisata shareholders to click here to le...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
21.01.2026
DGX
LISTED
NYSE
Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 12th Consecutive Year
News Preview
SECAUCUS, N.J., Jan. 21, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that it has been named to the Fortune® magazine 2026 World's Most Admired Companies™ list, for the 12th consecutive year....
Themefolio
Profiler
Peergroup
© PR Newswire
21.01.2026
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Transaction in Own Shares
News Preview
For immediate release
21 January 2026
WORLDWIDE HEALTHCARE TRUST PLC
(the "Company")
MARKET PURCHAS...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
21.01.2026
ONCO
LISTED
NEO
Onco-Innovations Engages i2i Marketing Group Engagement for Market Awareness Services
News Preview
VANCOUVER, BC / ACCESS Newswire / January 21, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") announces that it has engaged i2i Marketing Group, LLC (1107 Key Plaza, Suite 222, Key West, FL 33040, USA; email: contact@i2illc.com; telephone: (240) 315-4665; Contact:...
Themefolio
Profiler
Peergroup
© BusinessWire
21.01.2026
GALD
LISTED
XWSX
Galderma Provides Update on Arbitration Case Regarding Neuromodulator Research and Development Partnership
News Preview
Galderma (SIX:GALD), the pure-play dermatology category leader, today announced that an International Chamber of Commerce arbitral tribunal issued an award confirming the termination of a 2014 neuromodulator research & development partnership with Ipsen. The partnership was limited to the rights and obligations relating to the companies’ early...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
SN
LISTED
LSE
Smith+Nephew completes acquisition of Integrity Orthopaedics; establishes unrivalled portfolio for shoulder repair
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has completed the acquisition of Integrity Orthopaedics, further strengthening its sports medicine shoulder repair business with the most comprehensive suite of technologies available for rotator cuff repair (RCR)....
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
AB
LISTED
EURONEXT
AB Science receives Japanese patent protection for the use of masitinib in progressive forms of multiple sclerosis (MS) until 2041
News Preview
PRESS RELEASE...
Themefolio
Profiler
Peergroup
© BusinessWire
21.01.2026
EVFM
LISTED
OTC
Evofem Expands “Say Vagina” Campaign With Launch of Say Vagina Store
News Preview
Evofem Biosciences, Inc. (“Evofem” or the “Company”) (OTCID: EVFM) today announced the launch of the Say Vagina Store, expanding its groundbreaking Say Vagina campaign aimed at normalizing accurate anatomical language and advancing education and autonomy in women’s health.
“Say Vagina is an ongoing initiative designed to address the widespread c...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
OSE
LISTED
EURONEXT
OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101)
News Preview
OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101)...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
IBAB
LISTED
EURONEXT
IBA – TRANSPARENCY NOTIFICATION
News Preview
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings)...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
REGN
LISTED
NASDAQ
Nation’s Top 40 High School Scientists to Compete for $1.8 Million in Awards at the Prestigious Regeneron Science Talent Search
News Preview
The Regeneron Science Talent Search Honors America’s Brightest Young Scientists Advancing Discovery and Innovation The Regeneron Science Talent Search Honors America’s Brightest Young Scientists Advancing Discovery and Innovation...
Themefolio
Profiler
Peergroup
© EQS Newswire
21.01.2026
PHARM
LISTED
EURONEXT
First Berlin Equity Research GmbH: Pharming Group NV | Rating: Buy
News Preview
Original-Research: Pharming Group NV - from First Berlin Equity Research GmbH
21.01.2026 / 16:13 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude ......
Themefolio
Profiler
Peergroup
© BusinessWire
21.01.2026
GSK
LISTED
NYSE
GSK Awards $2M in COiMMUNITY Initiative Grants to Help Close Vaccination Gaps, Commits $3M for 2026
News Preview
GSK plc (LSE/NYSE: GSK) today announced the 2025 recipients of its COiMMUNITY Initiative grant program, awarding a total of $2 million across 16 state, regional and national non-profits working to improve immunization rates across the US. Through COiMMUNITY, GSK invests in local efforts to improve vaccine education and uptake. Now in its third yea...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
ALHC
LISTED
NASDAQ
Alignment Healthcare Named to the 2026 Fortune World’s Most Admired Companies™ List for First Time
News Preview
In its first year of eligibility, award-winning Medicare Advantage company earns spot on global corporate reputation list, joining major corporations like Amazon and Apple In its first year of eligibility, award-winning Medicare Advantage company earns spot on global corporate reputation list, joining major corporations like Amazon and Apple...
Themefolio
Profiler
Peergroup
© PR Newswire
21.01.2026
LLY
LISTED
NYSE
Lilly confirms date and conference call for fourth-quarter 2025 financial results announcement
News Preview
INDIANAPOLIS, Jan. 21, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter 2025 financial results on February 4, 2026. Lilly will also conduct a conference call that day with the investment community and media to further detail the company's financial performance. The conference call will begin at 10 a.m. Easte...
Themefolio
Profiler
Peergroup
© PR Newswire
21.01.2026
DVA
LISTED
NYSE
DaVita Inc. Schedules 4th Quarter 2025 Investor Conference Call
News Preview
DENVER, Jan. 21, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Monday, February 2, 2026 at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.This call is also being webcast and can be accessed at the D...
Themefolio
Profiler
Peergroup
© PR Newswire
21.01.2026
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC
LEI: 5493003YBCY4W1IMJU04
NET ASSET VALUE
The estimated un-audited net asset val...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
KDEV
LISTED
STO
Karolinska Development’s portfolio company Dilafor signs binding term sheet with Exeltis for a license agreement regarding tafoxiparin
News Preview
STOCKHOLM, SWEDEN – January 21, 2026. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Dilafor has signed a binding term sheet with Exeltis, a global Women’s Health company, for an exclusive semi-global license (excluding China and Japan) to its lead candidate drug tafoxiparin. Exeltis will fund pivotal...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
CSDX
LISTED
OTC
CS Group (OTCQB: CSDX) Announces Multi-Channel Sales Model, Global Logistics Partners, and Sustainable Innovation Roadmap for MEDUSA SDP
News Preview
CS Group (OTCQB: CSDX) Announces Multi-Channel Sales Model, Global Logistics Partners, and Sustainable Innovation Roadmap for MEDUSA SDP...
Themefolio
Profiler
Peergroup
© PR Newswire
21.01.2026
ATOS
LISTED
NASDAQ
Atossa Therapeutics' Founder and CEO Steven Quay, M.D., Ph.D. Named One of The Top 50 Healthcare Technology CEOs of 2025
News Preview
Recognized for Visionary Leadership and Advancing Innovative Therapies in Oncology and Healthcare TechnologySEATTLE, Jan. 21, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of high unmet clinical need, annou...
Themefolio
Profiler
Peergroup
© BusinessWire
21.01.2026
ZURA
LISTED
NASDAQ
Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer
News Preview
Zura Bio Limited (Nasdaq: ZURA) (“Zura” or the “Company”), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious and debilitating autoimmune and inflammatory diseases, today announced the appointment of Sandeep Kulkarni, M.D. as Chief Executive Officer (CEO),...
Themefolio
Profiler
Peergroup
© BusinessWire
21.01.2026
OWLT
LISTED
NYSE
Owlet’s First Baby Sleep Report Analyzes Data from Over 1.2 Million Owlet Monitored Babies
News Preview
Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today released its first annual Baby Sleep Report, a review of sleep data gathered from over the 1.2 million babies monitored by Owlet products in 2025. The global report analyzes nearly 900 million hours of monitored infant sleep from babies across 200 ge...
Themefolio
Profiler
Peergroup
© BusinessWire
21.01.2026
QTRX
LISTED
NASDAQ
Quanterix Announces Landmark JAMA Study Highlighting Prognostic Value of Multi-Analyte Approach to Blood-Based Alzheimer’s Risk Profiling
News Preview
Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced publication of a landmark study in the high impact journal JAMA Network Open, https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2842215. The study, led by researchers at Amsterdam...
Themefolio
Profiler
Peergroup
© BusinessWire
21.01.2026
TEM
LISTED
NASDAQ
Tempus Announces the Launch of Paige Predict
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the launch of Paige Predict, a suite of cutting-edge digital pathology applications that analyze hematoxylin and eosin (H&E) whole slide images to help inform testing decisions. The AI-powered solution is designed to pr...
Themefolio
Profiler
Peergroup
© PR Newswire
21.01.2026
NRSN
LISTED
NASDAQ
NeuroSense Granted U.S. Patent for Treatment of Alzheimer's Disease
News Preview
Patent protection extended through 2043Alzheimer's proof-of-concept study completedClinical and Biomarker Outcomes Expected in Q1 2026CAMBRIDGE, Mass., Jan. 21, 2026 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseas...
Themefolio
Profiler
Peergroup
© PR Newswire
21.01.2026
HOTH
LISTED
NASDAQ
Hoth Therapeutics Secures Major International Patent Milestone for HT-KIT Cancer Program, Strengthening Global Oncology IP Position
News Preview
Chinese Patent Approved Covering HT-KIT Technology Designed to Induce Cancer Cell Apoptosis, Expanding Protection in One of the World's Largest Oncology MarketsNEW YORK, Jan. 21, 2026 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on developing innovative therapeutics, today announced tha...
Themefolio
Profiler
Peergroup
© BusinessWire
21.01.2026
CRL
LISTED
NYSE
Charles River Enters Manufacturing Collaboration with Gazi University
News Preview
Charles River Laboratories International, Inc. (NYSE: CRL) and Gazi University Faculty of Medicine, today announced a gene therapy contract development and manufacturing organization (CDMO) collaboration, providing plasmid DNA for AAV production and in vitro efficacy studies.
“We are excited to build a strong collaboration with Gazi University,”...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
AONC
LISTED
OTC
Genesis Cancer and Blood Institute and American Oncology Network Welcome Endocrinologist Dr. Daryl Burrows and Nurse Practitioner Natalie Brown, APRN
News Preview
Genesis Cancer and Blood Institute and American Oncology Network Welcome Endocrinologist Dr. Daryl Burrows and Nurse Practitioner Natalie Brown, APRN...
Themefolio
Profiler
Peergroup
© PR Newswire
21.01.2026
PAVM
LISTED
NASDAQ
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard®
News Preview
NEW YORK, Jan. 21, 2026 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that it has been awarded a contract by the U.S. Department of Veterans Affairs (VA) for its EsoGuard® Esophageal DN...
Themefolio
Profiler
Peergroup
© PR Newswire
21.01.2026
45680
LISTED
XJPX
Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology
News Preview
Investment in Canadian headquarters fuels expansion of Canadian operations, advancing access to innovative cancer medicinesTORONTO, Jan. 21, 2026 /CNW/ - Daiichi Sankyo (TSE: 4568) has further established its presence in Canada with the official opening of its permanent headquarters in Toronto, including additional operational and research and dev...
Themefolio
Profiler
Peergroup
© PR Newswire
21.01.2026
45680
LISTED
XJPX
Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology
News Preview
Investment in Canadian headquarters fuels expansion of Canadian operations, advancing access to innovative cancer medicinesTORONTO, Jan. 21, 2026 /PRNewswire/ -- Daiichi Sankyo (TSE: 4568) has further established its presence in Canada with the official opening of its permanent headquarters in Toronto, including additional operational and research...
Themefolio
Profiler
Peergroup
© PR Newswire
21.01.2026
45680
LISTED
XJPX
Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology
News Preview
Investment in Canadian headquarters fuels expansion of Canadian operations, advancing access to innovative cancer medicinesTORONTO, Jan. 21, 2026 /PRNewswire/ - Daiichi Sankyo (TSE: 4568) has further established its presence in Canada with the official opening of its permanent headquarters in Toronto, including additional operational and research...
Themefolio
Profiler
Peergroup
© PR Newswire
21.01.2026
45680
LISTED
XJPX
Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology
News Preview
Investment in Canadian headquarters fuels expansion of Canadian operations, advancing access to innovative cancer medicinesTORONTO, Jan. 21, 2026 /PRNewswire/ -- Daiichi Sankyo (TSE: 4568) has further established its presence in Canada with the official opening of its permanent headquarters in Toronto, including additional operational and research...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
OCGN
LISTED
NASDAQ
Ocugen, Inc. Announces Pricing of $22.5 Million Offering of Common Stock
News Preview
MALVERN, Pa., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Nasdaq: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced the pricing of its underwritten offering of 15,000,000 shares of its common stock at an offering price of $1.50 per share of common stock for gross proceeds of $22.5 million, befo...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
SLXN
LISTED
NASDAQ
Silexion Therapeutics to Attend 7th Annual RNAi-Based Therapeutics Summit
News Preview
Grand Cayman, Cayman Island, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (“Silexion” or the “Company”), a clinical-stage, oncology-focused biotechnology company, today announced that Company management, including CEO Ilan Hadar, will attend the 7th RNAi-Based Therapeutics Summit, taking place January 27-29 in Boston, MA. ...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
LXRX
LISTED
NASDAQ
Lexicon Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA For Pilavapadin in the Treatment of Diabetic Peripheral Neuropathic Pain
News Preview
– No objections raised by FDA to advancement of pilavapadin into Phase 3 development utilizing two-arm registrational studies of 10 mg daily dose compared to placebo – – No objections raised by FDA to advancement of pilavapadin into Phase 3 development utilizing two-arm registrational studies of 10 mg daily dose compared to placebo –...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
ENTX
LISTED
NASDAQ
Entera Bio Announces Upcoming Q1 2026 Corporate Priorities and Pipeline Outlook
News Preview
Final EB613 Phase 3 Protocol Submission to FDA Planned for Q1 2026, Following December 19th 2025 FDA Ruling...
Themefolio
Profiler
Peergroup
© PR Newswire
21.01.2026
9911
LISTED
HKSE
Newborn Town Inc. Expects 2025 Revenue of RMB 6.76-7.00 Billion, Up Over 32% Year on Year
News Preview
HONG KONG, Jan. 21, 2026 /PRNewswire/ -- Newborn Town Inc. (Newborn Town or the company, stock code: 09911.HK), a leading global social entertainment company, released its unaudited operating data for 2025.For the year ended 31 December 2025, the company's total revenue is estimated to reach approximately RMB 6,760 million to RMB 7,000 million, re...
Themefolio
Profiler
Peergroup
© BusinessWire
21.01.2026
WELL
LISTED
TSX
WELL Health Releases CEO Letter to Shareholders
News Preview
WELL Health Technologies Corp. (TSX: WELL, OTCQX: WHTCF) (the “Company” or “WELL”), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce the release of a letter to shareholders from its Founder, Chairman and Chie...
Themefolio
Profiler
Peergroup
© BusinessWire
21.01.2026
IONS
LISTED
NASDAQ
DAWNZERA™ (donidalorsen) approved in the European Union for hereditary angioedema (HAE)
News Preview
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced that the European Commission (EC) has approved DAWNZERA™ (donidalorsen) in the European Union (EU) for the routine prevention of recurrent attacks of hereditary angioedema (HAE) in adults and adolescents aged 12 years and older. The approval fol...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
ARQT
LISTED
NASDAQ
Nationwide Survey Underscores Concerns with Use of Topical Steroids and Need for Long-Term Treatment Strategies Facing the 46 Million Americans with Chronic Inflammatory Skin Conditions
News Preview
Survey Underscores Concerns with Use of Topical Steroids and Need for Long-Term Treatment Plans For Those With Chronic Inflammatory Skin Conditions...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
ECOR
LISTED
NASDAQ
Acacia Clinics and Vagus Nerve Society Conduct Study Using electroCore’s gammaCore Sapphire for Adjunctive Treatment of Symptoms Associated with Post-Traumatic Stress Disorder (“PTSD”)
News Preview
ROCKAWAY, N.J., Jan. 21, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a bioelectronic technology company, today announced that Acacia Clinics and the Vagus Nerve Society have launched a new research initiative to explore the extent to which gammaCore™ Sapphire, electroCore’s non-invasive vagus nerve...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
LEGN
LISTED
NASDAQ
Legend Biotech to Present CARVYKTI® Data at 2026 Tandem Meetings Reinforcing Growing Evidence Supporting Earlier Use
News Preview
Six poster presentations highlight CARVYKTI® efficacy, safety, and real-world outcomes across CARTITUDE trials and analyses, reflecting a maturing and expanding body of evidence...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
INNV
LISTED
NASDAQ
InnovAge to Announce Fiscal Second Quarter 2026 Financial Results and Host Conference Call Tuesday, February 3, 2026
News Preview
InnovAge to Announce Fiscal Second Quarter 2026 Financial Results and Host Conference Call Tuesday, February 3, 2026...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
ALGS
LISTED
NASDAQ
Aligos Therapeutics Provides Phase 2 B-SUPREME Study Progress Updates
News Preview
Interim analyses on track for the first and second half of 2026 Interim analyses on track for the first and second half of 2026...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
SBTX
LISTED
NASDAQ
California K-12 Schools Now Eligible for neffyinSchools Program, Offering Needle-Free Epinephrine at No Cost for Emergency Use
News Preview
California joins 23 other states eligible to receive free neffy® (epinephrine nasal spray) at schools...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2026
ARTV
LISTED
NASDAQ
Artiva Biotherapeutics Announces Upcoming Presentations at the 2026 Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR® (Tandem Meetings) Highlighting Cost-Effectiveness of AlloNK in a Community Rheumatology Practice and Continued Durability
News Preview
SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV) (Artiva), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with devastating autoimmune diseases and cancers, today announced presentations at the 2026 Transplantation & Cellular...
Themefolio
Profiler
Peergroup
© PR Newswire
21.01.2026
QDEL
LISTED
NASDAQ
QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results
News Preview
SAN DIEGO, Jan. 21, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of in vitro diagnostics, announced today that it will report its financial results for the fourth quarter and full year 2025 ended December 28, 2025, after the market close on Wednesday, February 11, 2026....
Themefolio
Profiler
Peergroup
© PR Newswire
21.01.2026
BDX
LISTED
NYSE
BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market
News Preview
The enhanced collaboration and innovation will improve options for pharmaceutical companies and patients requiring large-volume self-injection systemsLE PONT-DE-CLAIX, France and BURGDORF, Switzerland, Jan. 21, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Ypsomed, a leading d...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
